医薬品有効成分の世界市場レポート 2025年

医薬品有効成分の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.3％で3,261億3,000万米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、希少疾患への注目の高まり、バイオシミラー市場の拡大、グリーンケミストリーの進歩、継続的製造への注力、イノベーションに対する規制当局の支援、臨床試験のグローバル化、持続可能で倫理的な実践への注力などに起因すると考えられます。予測期間における主な開発動向としては、医薬品開発のデジタル化、先端製造技術への投資、希少疾患・希少疾病用医薬品向け原薬、品質に関する規制当局の監視、原薬のシリアル化とトレーサビリティ、バイオ医薬品とバイオテクノロジー製品などが挙げられます。

慢性疾患の蔓延拡大は、医薬品有効成分（API）市場の成長促進要因になると予想されます。慢性疾患は3ヶ月以上持続し、多くの場合時間とともに悪化するもので、がん、心臓病、脳卒中、糖尿病、関節炎などの疾患を含みます。APIは、腫瘍学、心臓病学、神経学、整形外科学など様々な病気に対応する高品質の医薬品に不可欠です。例えば、国際糖尿病連合は、糖尿病患者が2030年までに5億7,800万人、2045年までに7億人と大幅に増加し、糖尿病関連死亡のほぼ半数が60歳未満の成人で発生し、死亡原因のトップ10に入ると予測しています。したがって、慢性疾患の罹患率の上昇はAPI市場の成長を促進すると予想されます。

研究開発（R&D）投資の増加は、今後数年間の医薬品有効成分（API）市場の成長を促進すると予測されます。研究開発投資は、新しい知識の創出、革新的な製品、サービス、プロセスの開発、既存の製品の強化を目的とした活動に、資金的、人的、技術的な資源を配分することを含みます。研究開発は、イノベーションを促進し、製品の品質を向上させ、製薬業界の進歩を推進するため、原薬の進歩にとって不可欠です。バイオ医薬品企業や政府機関は、治療成績の向上やアンメットメディカルニーズへの対応を目指した革新的な原薬や製剤を創出するために研究開発に投資しています。例えば、カナダの政府機関であるカナダ統計局は2024年9月、カナダ企業が2022年に社内の研究開発に費やした金額は過去最高の304億米ドルに達し、2021年から9.4％増加したと報告しています。このように、研究開発への投資の拡大は、医薬品有効成分市場の拡大を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の医薬品有効成分市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の医薬品有効成分市場：成長率分析
• 世界の医薬品有効成分市場の実績：規模と成長、2019～2024年
• 世界の医薬品有効成分市場の予測：規模と成長、2024～2029年、2034年
• 世界の医薬品有効成分総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品有効成分市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 革新的API（医薬品有効成分）
• ジェネリックAPI（医薬品有効成分）
• 世界の医薬品有効成分市場：メーカー別、実績と予測、2019～2024年、2024～2029年、2034年
• キャプティブメーカー
• マーチャントメーカー
• 世界の医薬品有効成分市場：薬の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 処方薬
• 市販薬
• 世界の医薬品有効成分市場：治療用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 伝染病
• 腫瘍学
• 糖尿病
• 心血管疾患
• 疼痛管理
• 呼吸器疾患
• その他
• 世界の医薬品有効成分市場：革新的APIのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生物学的製剤
• 新規化学物質（NCE）
• 標的治療薬
• 世界の医薬品有効成分市場：ジェネリックAPIのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 特許切れ医薬品
• バイオシミラー
• 市販ジェネリック医薬品

第7章 地域別・国別分析

• 世界の医薬品有効成分市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の医薬品有効成分市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品有効成分市場：競合情勢
• 医薬品有効成分市場：企業プロファイル
  • Albemarle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cipla Limited
• Boehringer Ingelheim International GmbH
• Merck KGaA
• Sun Pharmaceutical Industries Limited
• Bristol-Myers Squibb Company
• Mylan Pharmaceuticals ULC
• BASF SE
• Lupin Limited
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche AG
• Pfizer Inc.
• Novartis International AG
• Sanofi S.A
• Viatris Inc.
• Cadila Pharmaceuticals Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品有効成分市場2029年：新たな機会を提供する国
• 医薬品有効成分市場2029年：新たな機会を提供するセグメント
• 医薬品有効成分市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An active pharmaceutical ingredient (API) is a crucial component or substance utilized in the production of a finished pharmaceutical product (FPP). It is specifically designed to exhibit pharmacological action or directly impact the treatment, mitigation, cure, or prevention of diseases. APIs also play a role in restoring, correcting, or modifying human physiological processes.

There are two main types of active pharmaceutical ingredients such as innovative APIs and generic APIs. Innovative APIs are associated with drugs containing active ingredients or combinations that have not been previously approved. These are often used to offer unique treatments for conditions lacking effective existing remedies. Manufacturers of APIs can be categorized as captive manufacturers and merchant manufacturers. The synthesis types of APIs include synthetic APIs and biotech APIs. These ingredients find applications in both prescription and over-the-counter drugs, targeting therapeutic areas such as communicable diseases, oncology, diabetes, cardiovascular disease, pain management, respiratory diseases, and others.

The active pharmaceutical ingredients market research report is one of a series of new reports from The Business Research Company that provides active pharmaceutical ingredients market statistics, including active pharmaceutical ingredients industry global market size, regional shares, competitors with an active pharmaceutical ingredients market share, detailed active pharmaceutical ingredients market segments, market trends and opportunities, and any further data you may need to thrive in the active pharmaceutical ingredients industry. These active pharmaceutical ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The active pharmaceutical ingredients market size has grown strongly in recent years. It will grow from $230.83 billion in 2024 to $246.41 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to advancements in drug development, expansion of generic drug market, globalization of pharmaceutical manufacturing, regulatory initiatives for drug safety, rise in contract manufacturing organizations (CMOs), focus on precision medicine, emergence of biopharmaceuticals, global pandemics and health threats.

The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. It will grow to $326.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing healthcare expenditure, increasing focus on rare diseases, expansion of biosimilars market, advancements in green chemistry, focus on continuous manufacturing, regulatory support for innovation, globalization of clinical trials, focus on sustainable and ethical practices. Major trends in the forecast period include digitalization of drug development, investment in advanced manufacturing technologies, APIs for rare diseases and orphan drugs, regulatory scrutiny on quality, API serialization and traceability, biopharmaceuticals and biotechnology products.

The expanding prevalence of chronic diseases is anticipated to be a driving factor for the growth of the active pharmaceutical ingredients (API) market. Chronic diseases, persisting for three months or more and often worsening over time, encompass conditions like cancer, heart disease, stroke, diabetes, and arthritis. APIs are integral to high-quality medications addressing various illnesses such as oncology, cardiology, neurology, and orthopedics. For instance, the International Diabetes Federation predicts a significant rise in diabetes cases to 578 million by 2030 and 700 million by 2045, with nearly half of diabetes-related deaths occurring in adults under 60, making it a top 10 cause of mortality. Hence, the escalating incidence of chronic diseases is expected to propel growth in the API market.

The rising investment in research and development (R&D) is projected to drive the growth of the active pharmaceutical ingredients (APIs) market in the coming years. Investment in R&D involves allocating resources-financial, human, and technological-toward activities aimed at generating new knowledge, developing innovative products, services, or processes, and enhancing existing offerings. R&D is vital for the advancement of APIs, as it fosters innovation, improves product quality, and propels progress in the pharmaceutical industry. Biopharmaceutical companies and government agencies invest in R&D to create innovative APIs and formulations that aim to enhance treatment outcomes and address unmet medical needs. For example, in September 2024, Statistics Canada, a Canadian government agency, reported that Canadian businesses spent a record $30.4 billion on in-house R&D in 2022, marking a 9.4% increase from 2021. Thus, the growing investment in R&D is a key factor driving the expansion of the active pharmaceutical ingredients market.

Technological advancements represent a pivotal trend gaining traction within the active pharmaceutical ingredients market. Leading market players are directing efforts toward implementing innovative technologies and methods for optimized API production. Techniques like continuous flow chemistry, advancements in lyophilization, powder handling, and process control are focal points for major companies aiming to maintain their market standing. A notable example involves the collaboration between NovAliX, ALYSOPHIL SAS, De Dietrich Process Systems, and Bruker in May 2022. This partnership introduced a groundbreaking approach to API production through the PIPAc (Production Intelligente de Principes Actifs) project. PIPAc aims to revolutionize API manufacturing by minimizing complex supply chains in pharmaceutical production and developing rapid-response mobile API production units for global deployment. Leveraging cutting-edge synthesis, continuous flow chemistry, in-flow analysis, and artificial intelligence, PIPAc seeks to create next-generation, autonomous, and optimized units.

Leading firms within the active pharmaceutical ingredients (API) sector are concentrating on the introduction of pioneering solutions, like Capsugel Enprotect, aimed at driving their market revenues. An innovative API solution represents an advanced pharmaceutical compound serving as the biologically active element in drug products. For example, in November 2022, Lonza Group AG unveiled Capsugel Enprotect, a groundbreaking capsule solution designed to transport acid-sensitive active pharmaceutical ingredients to the intestine. This coating-free capsule, a first of its kind, expedites drug development timelines by simplifying the manufacturing process, as it remains intact during stomach transit and releases its contents solely in the intestine. This innovative delivery method is tailored for use with small molecules, proteins, peptides, RNA-based medicines, and even aids in delivering living biotherapeutic products-an innovative class of medical interventions.

In September 2023, Barentz BV, a Netherlands-based company specializing in the distribution of ingredients and specialty chemicals, acquired Unijaya for an undisclosed amount. This acquisition is intended to strengthen Barentz BV's market position, expand its product offerings, and enhance its service capabilities. Unijaya is an Indonesian manufacturing company that plays a significant role in the distribution of Active Pharmaceutical Ingredients.

Major companies operating in the active pharmaceutical ingredients market are Albemarle Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, AbbVie Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Boehringer Ingelheim International GmbH, Merck KGaA, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Mylan Pharmaceuticals ULC, BASF SE, Lupin Limited, Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Pfizer Inc., Novartis International AG, Sanofi S.A, Viatris Inc., Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals Inc., Apotex Inc., Lonza Group AG, HPM Chemicals and Fertilizers Ltd., GlaxoSmithKline PLC, Godrej Consumer Products, Daiichi Sankyo Inc., Catalent Inc.

North America was the largest region in the active pharmaceutical ingredients market share in 2024. The regions covered in the active pharmaceutical ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the active pharmaceutical ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The active pharmaceutical ingredient market consists of sales of active pharmaceutical ingredients that are used in final pharmaceutical products such as drug products (tablet, pill, cream, or injectable) to deliver a desired effect. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Active Pharmaceutical Ingredients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on active pharmaceutical ingredients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for active pharmaceutical ingredients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The active pharmaceutical ingredients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Innovative APIs (Active Pharmaceutical Ingredient); Generic APIs (Active Pharmaceutical Ingredient)
• 2) By Manufacturer: Captive Manufacturers; Merchant Manufacturers
• 3) By Type Of Drug: Prescription Drugs; Over-The-Counter Drugs
• 4) By Therapeutic Application: Communicable Diseases; Oncology; Diabetes; Cardiovascular Disease; Pain Management; Respiratory Diseases; Other Therapeutic Applications
• Subsegments:
• 1) By Innovative APIs: Biologics; Novel Chemical Entities (NCEs); Targeted Therapies
• 2) By Generic APIs: Off-Patent Pharmaceuticals; Biosimilars; Over-The-Counter (OTC) Generic Drugs
• Companies Mentioned: Albemarle Corporation; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Limited; AbbVie Inc.; Teva Pharmaceutical Industries Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Active Pharmaceutical Ingredients Market Characteristics

3. Active Pharmaceutical Ingredients Market Trends And Strategies

4. Active Pharmaceutical Ingredients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Active Pharmaceutical Ingredients Growth Analysis And Strategic Analysis Framework

• 5.1. Global Active Pharmaceutical Ingredients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Active Pharmaceutical Ingredients Market Growth Rate Analysis
• 5.4. Global Active Pharmaceutical Ingredients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Active Pharmaceutical Ingredients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Active Pharmaceutical Ingredients Total Addressable Market (TAM)

6. Active Pharmaceutical Ingredients Market Segmentation

• 6.1. Global Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Innovative APIs (Active Pharmaceutical Ingredient)
• Generic APIs (Active Pharmaceutical Ingredient)
• 6.2. Global Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Captive Manufacturers
• Merchant Manufacturers
• 6.3. Global Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Drugs
• Over-The-Counter Drugs
• 6.4. Global Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Communicable Diseases
• Oncology
• Diabetes
• Cardiovascular Disease
• Pain Management
• Respiratory Diseases
• Other Therapeutic Applications
• 6.5. Global Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Innovative APIs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics
• Novel Chemical Entities (NCEs)
• Targeted Therapies
• 6.6. Global Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Generic APIs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Off-Patent Pharmaceuticals
• Biosimilars
• Over-The-Counter (OTC) Generic Drugs

7. Active Pharmaceutical Ingredients Market Regional And Country Analysis

• 7.1. Global Active Pharmaceutical Ingredients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Active Pharmaceutical Ingredients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Active Pharmaceutical Ingredients Market

• 8.1. Asia-Pacific Active Pharmaceutical Ingredients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Active Pharmaceutical Ingredients Market

• 9.1. China Active Pharmaceutical Ingredients Market Overview
• 9.2. China Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Active Pharmaceutical Ingredients Market

• 10.1. India Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Active Pharmaceutical Ingredients Market

• 11.1. Japan Active Pharmaceutical Ingredients Market Overview
• 11.2. Japan Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Active Pharmaceutical Ingredients Market

• 12.1. Australia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Active Pharmaceutical Ingredients Market

• 13.1. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Active Pharmaceutical Ingredients Market

• 14.1. South Korea Active Pharmaceutical Ingredients Market Overview
• 14.2. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Active Pharmaceutical Ingredients Market

• 15.1. Western Europe Active Pharmaceutical Ingredients Market Overview
• 15.2. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Active Pharmaceutical Ingredients Market

• 16.1. UK Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Active Pharmaceutical Ingredients Market

• 17.1. Germany Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Active Pharmaceutical Ingredients Market

• 18.1. France Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Active Pharmaceutical Ingredients Market

• 19.1. Italy Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Active Pharmaceutical Ingredients Market

• 20.1. Spain Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Active Pharmaceutical Ingredients Market

• 21.1. Eastern Europe Active Pharmaceutical Ingredients Market Overview
• 21.2. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Active Pharmaceutical Ingredients Market

• 22.1. Russia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Active Pharmaceutical Ingredients Market

• 23.1. North America Active Pharmaceutical Ingredients Market Overview
• 23.2. North America Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Active Pharmaceutical Ingredients Market

• 24.1. USA Active Pharmaceutical Ingredients Market Overview
• 24.2. USA Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Active Pharmaceutical Ingredients Market

• 25.1. Canada Active Pharmaceutical Ingredients Market Overview
• 25.2. Canada Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Active Pharmaceutical Ingredients Market

• 26.1. South America Active Pharmaceutical Ingredients Market Overview
• 26.2. South America Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Active Pharmaceutical Ingredients Market

• 27.1. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Active Pharmaceutical Ingredients Market

• 28.1. Middle East Active Pharmaceutical Ingredients Market Overview
• 28.2. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Active Pharmaceutical Ingredients Market

• 29.1. Africa Active Pharmaceutical Ingredients Market Overview
• 29.2. Africa Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Active Pharmaceutical Ingredients Market Competitive Landscape And Company Profiles

• 30.1. Active Pharmaceutical Ingredients Market Competitive Landscape
• 30.2. Active Pharmaceutical Ingredients Market Company Profiles
  • 30.2.1. Albemarle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

31. Active Pharmaceutical Ingredients Market Other Major And Innovative Companies

• 31.1. Cipla Limited
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Merck KGaA
• 31.4. Sun Pharmaceutical Industries Limited
• 31.5. Bristol-Myers Squibb Company
• 31.6. Mylan Pharmaceuticals ULC
• 31.7. BASF SE
• 31.8. Lupin Limited
• 31.9. Johnson & Johnson Services Inc.
• 31.10. F. Hoffmann-La Roche AG
• 31.11. Pfizer Inc.
• 31.12. Novartis International AG
• 31.13. Sanofi S.A
• 31.14. Viatris Inc.
• 31.15. Cadila Pharmaceuticals Limited

32. Global Active Pharmaceutical Ingredients Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Active Pharmaceutical Ingredients Market

34. Recent Developments In The Active Pharmaceutical Ingredients Market

35. Active Pharmaceutical Ingredients Market High Potential Countries, Segments and Strategies

• 35.1 Active Pharmaceutical Ingredients Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Active Pharmaceutical Ingredients Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Active Pharmaceutical Ingredients Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer